The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive profiling of circulating tumor DNA and microbial landscapes in nasopharyngeal cancer across Asia: NCCH1905/A-TRAIN study.
 
Thinh Nguyen
No Relationships to Disclose
 
Yuki Kojima
No Relationships to Disclose
 
Taisuke Mori
No Relationships to Disclose
 
Kazuki Sudo
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Janssen; MSD; Nihon Medi-Physics; Pfizer
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Loxo/Lilly; Merck; NanoCarrier; Pfizer; PRA Health Sciences; Takeda
 
Pei Jye Voon
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Johnson & Johnson/Janssen; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer
Speakers' Bureau - Amgen; AstraZeneca; Johnson & Johnson/Janssen; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer
Research Funding - Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Johnson & Johnson/Janssen (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Revolution Medicines (Inst); ROCHE (Inst); Viracta Therapeutics (Inst)
 
Charuwan Akewanlop
No Relationships to Disclose
 
Arunee Dechaphunkul
No Relationships to Disclose
 
Naiyarat Prasongsook
No Relationships to Disclose
 
Marcelo Severino Imasa
Consulting or Advisory Role - AstraZeneca; Pfizer
Speakers' Bureau - AstraZeneca; MSD; Pfizer; Roche; Sandoz
Research Funding - MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Pei-Jen Lou
No Relationships to Disclose
 
Darren Wan-Teck Lim
No Relationships to Disclose
 
Dang Thinh
No Relationships to Disclose
 
Kensuke Suzuki
Employment - Illumina
 
Ryo Itaya
Employment - Illumina
 
Yukari Nagasaka
No Relationships to Disclose
 
Ryunosuke Machida
No Relationships to Disclose
 
Tetsuya Sasaki
No Relationships to Disclose
 
Tomomi Hata
No Relationships to Disclose
 
Kenichi Nakamura
Honoraria - Chugai Pharma; Taiho Pharmaceutical; Takeda
Research Funding - Astellas Pharma (Inst); Boehringer Ingelheim Seiyaku (Inst); Bristol-Myers Squibb Japan (Inst); Chugai/Roche (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Merck (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Pfizer (Inst); SERVIER (Inst); SymBio Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Kan Yonemori
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo/Astra Zeneca; Eisai; Fujifilm; Lilly Japan; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Chugai Pharma; Eisai; EP biopharma; Haihe Pharmaceutical; Henlius; Novartis; OncXerna Therapeutics; Ono Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Eisai (Inst); Genmab (Inst); Haihe Pharmaceutical (Inst); Kyowa Hakko Kirrin (Inst); Lilly (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)